More EXAS factoids (from JMP webcast)—75% of the $14B US disease burden of colorectal cancer is borne by Medicare. The $14B figure is expected to rise to $17B in the next few years.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”